Literature DB >> 9092590

Molecular cloning and characterization of an L-epinephrine transporter from sympathetic ganglia of the bullfrog, Rana catesbiana.

S Apparsundaram1, K R Moore, M D Malone, H C Hartzell, R D Blakely.   

Abstract

Chemical signaling by dopamine (DA) and L-norepinephrine (L-NE) at synapses is terminated by uptake via specialized presynaptic transport proteins encoded by the DA transporter (DAT) and L-NE transporter (NET) genes, respectively. In some vertebrate neurons, particularly the sympathetic neurons of amphibians, L-NE is converted to L-epinephrine (L-Epi, adrenaline) and released as the primary neurotransmitter. Although evidence exists for a molecularly distinct L-Epi transporter (ET) in the vertebrate brain and peripheral nervous system, a transporter specialized for extracellular L-Epi clearance has yet to be identified. To pursue this issue, we cloned transporter cDNAs from bullfrog (Rana catesbiana) paravertebral sympathetic ganglia and characterized functional properties via heterologous expression in non-neuronal cells. A cDNA of 2514 bp (fET) was identified for which the cognate 3.1 kb mRNA is highly enriched in frog sympathetic ganglia. Sequence analysis of the fET cDNA reveals an open reading frame coding for a protein of 630 amino acids. Inferred fET protein sequence bears 75, 66, and 48% amino acid identity with human NET, DAT, and the 5-hydroxytryptamine transporter (SERT), respectively. Transfection of fET confers Na+- and Cl--dependent catecholamine uptake in HeLa cells. Uptake of [3H]-L-NE by fET is inhibited by catecholamines in a stereospecific manner. L-Epi and DA inhibit fET-mediated [3H]-L-NE uptake more potently than they inhibit [3H]-L-NE uptake by human NET (hNET), whereas L-NE exhibits equivalent potency between the two carriers. Moreover, fET exhibits a greater maximal velocity (Vmax) for the terminal products of catecholamine biosynthesis (L-Epi > L-NE >> DA), unlike hNET, in which a Vmax rank order of L-NE > DA > L-Epi is observed. fET-mediated transport of catecholamines is sensitive to cocaine and tricyclic antidepressants, with antagonist potencies significantly correlated with hNET inhibitor sensitivity. Amino acid conservation and divergence of fET with mammalian catecholamine transporters help define residues likely to be involved in catecholamine recognition and translocation as well as blockade by selective reuptake inhibitors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9092590      PMCID: PMC6573121     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  87 in total

Review 1.  Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations.

Authors:  R B Pearson; B E Kemp
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

2.  Changes in sizes of the adrenaline-containing vesicles and their cores in frog cardiac sympathetic nerves after pharmacological treatments.

Authors:  R I Woods
Journal:  J Neurocytol       Date:  1977-08

3.  A receptor kinetic model of a vascular neuroeffector.

Authors:  B Johansson; S R Johansson; B Ljung; L Stage
Journal:  J Pharmacol Exp Ther       Date:  1972-03       Impact factor: 4.030

Review 4.  An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1987-10-26       Impact factor: 16.971

5.  Epinephrine in rat hypothalamus: antagonism by desipramine of 6-hydroxydopamine-induced depletion.

Authors:  R E Tessel; L E Kennedy; S K Burgess; R T Borchardt
Journal:  Brain Res       Date:  1978-09-29       Impact factor: 3.252

6.  Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter.

Authors:  C Pifl; O Hornykiewicz; B Giros; M G Caron
Journal:  J Pharmacol Exp Ther       Date:  1996-06       Impact factor: 4.030

7.  Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor.

Authors:  C D Strader; M R Candelore; W S Hill; I S Sigal; R A Dixon
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

8.  Organization of central adrenergic pathways: I. Relationships of ventrolateral medullary projections to the hypothalamus and spinal cord.

Authors:  D C Tucker; C B Saper; D A Ruggiero; D J Reis
Journal:  J Comp Neurol       Date:  1987-05-22       Impact factor: 3.215

9.  Phenylethanolamine N-methyltransferase activity is decreased in Alzheimer's disease brains.

Authors:  W J Burke; H D Chung; B R Nakra; G T Grossberg; T H Joh
Journal:  Ann Neurol       Date:  1987-08       Impact factor: 10.422

10.  Immunohistochemistry of tyrosine hydroxylase and phenylethanolamine N-methyltransferase in the human brain stem: description of adrenergic perikarya and characterization of longitudinal catecholaminergic pathways.

Authors:  K Kitahama; L Denoroy; M Goldstein; M Jouvet; J Pearson
Journal:  Neuroscience       Date:  1988-04       Impact factor: 3.590

View more
  3 in total

1.  Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humans.

Authors:  Utkarsh Kohli; Maureen K Hahn; Brett A English; Gbenga G Sofowora; Mordechai Muszkat; Chun Li; Randy D Blakely; C Michael Stein; Daniel Kurnik
Journal:  Pharmacogenet Genomics       Date:  2011-04       Impact factor: 2.089

2.  The evolution of dopamine systems in chordates.

Authors:  Kei Yamamoto; Philippe Vernier
Journal:  Front Neuroanat       Date:  2011-03-29       Impact factor: 3.856

3.  Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors.

Authors:  Hubert J Sijben; Wieke M van Oostveen; Peter B R Hartog; Laura Stucchi; Andrea Rossignoli; Giovanna Maresca; Lia Scarabottolo; Adriaan P IJzerman; Laura H Heitman
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.